Influenza and pneumonia vaccination rates and factors affecting vaccination among patients with chronic obstructive pulmonary disease

dc.contributor.authorAktürk, Ülkü Aka
dc.contributor.authorŞengül, Aysun
dc.contributor.authorŞalepci, Banu Musaffa
dc.contributor.authorOktay, Nuray
dc.contributor.authorDüger, Mustafa
dc.contributor.authorTaşyıkan, Hale Arık
dc.contributor.authorKoçak, Nagihan Durmuş
dc.contributor.buuauthorDilektaşlı, Aslı Görek
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Göğüs Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.scopusid36466376600tr_TR
dc.date.accessioned2022-12-30T12:06:18Z
dc.date.available2022-12-30T12:06:18Z
dc.date.issued2016-12-12
dc.description.abstractBackground: Influenza and pneumococcal vaccinations are recommended in chronic obstructive pulmonary disease patients to decrease associated risks at all stages. Although the prevalence of chronic obstructive pulmonary disease is high in our country, as previously reported, vaccination rates are low. Aims: To assess the vaccination rates of chronic obstructive pulmonary disease patients and factors that may affect these. Study Design: Multi-centre cross-sectional study. Methods: Patients admitted to the chest diseases clinics of six different centres between 1 February 2013 and 1 January 2014 with a pre-diagnosis of Chronic obstructive pulmonary disease according to the Global initiative for chronic obstructive lung disease criteria, who were in a stable condition were included in the study. The survey, which included demographic characteristics, socioeconomic status, severity of disease and vaccination information, was first tested on a small patient population before the study. The survey was completed by the investigators after obtaining written informed consent. Results: The average age of the 296 included patients was 66.3 +/- 9.3 years and 91.9% were male. Of these, 36.5% had the influenza vaccination and 14.1% had the pneumococcal vaccination. The most common reason for not being vaccinated was 'no recommendation by doctors': 57.2% in the case of influenza vaccinations, and 46.8% in the case of pneumococcal vaccinations. Both vaccination rates were significantly higher in those patients with comorbidities (influenza vaccination p<0.001; pneumococcal vaccination p=0.06). There was no significant correlation with age, gender, smoking and severity of disease (p>0.05). Vaccination rates were significantly higher in those with a white-collar occupation and higher education level, and who presented to a university hospital (p<0.001). Conclusion: Medical professionals do not request vaccinations as often as the International Guidelines suggest for chronic obstructive pulmonary disease patients. Awareness of the importance of these vaccinations among both doctors and patients needs to be addressed.en_US
dc.identifier.citationAktürk, Ü. A. vd. (2017). ''Influenza and pneumonia vaccination rates and factors affecting vaccination among patients with chronic obstructive pulmonary disease''. Balkan Medical Journal, 34(3), 206-211.tr_TR
dc.identifier.endpage211tr_TR
dc.identifier.issn2146-3123
dc.identifier.issue3tr_TR
dc.identifier.pubmed28443565tr_TR
dc.identifier.scopus2-s2.0-85019707994tr_TR
dc.identifier.startpage206tr_TR
dc.identifier.urihttps://doi.org/10.4274/balkanmedj.2016.1028
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450859/
dc.identifier.uri2146-3131
dc.identifier.urihttp://hdl.handle.net/11452/30195
dc.identifier.volume34tr_TR
dc.identifier.wos000407614500004
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.trdizinTrDizintr_TR
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherGalenos Yayıncılıktr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.collaborationYurt içitr_TR
dc.relation.journalBalkan Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGeneral & internal medicineen_US
dc.subjectChronic obstructive pulmonary diseaseen_US
dc.subjectInfluenza vaccinationen_US
dc.subjectPneumonia vaccinationen_US
dc.subjectPreventionen_US
dc.subjectAdultsen_US
dc.subjectCopden_US
dc.subjectDeterminantsen_US
dc.subjectPopulationen_US
dc.subjectPrevalenceen_US
dc.subjectCoverageen_US
dc.subjectHealthen_US
dc.subjectAsthmaen_US
dc.subjectOlderen_US
dc.subject.emtreeInfluenza vaccineen_US
dc.subject.emtreePneumococcus vaccineen_US
dc.subject.emtreeInfluenza vaccineen_US
dc.subject.emtreePneumococcus vaccineen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAgeen_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeChronic obstructive lung diseaseen_US
dc.subject.emtreeClinical assessment toolen_US
dc.subject.emtreeComorbidityen_US
dc.subject.emtreeCross-sectional studyen_US
dc.subject.emtreeDemographyen_US
dc.subject.emtreeDiabetes mellitusen_US
dc.subject.emtreeDisease severityen_US
dc.subject.emtreeDrug informationen_US
dc.subject.emtreeEducational statusen_US
dc.subject.emtreeGenderen_US
dc.subject.emtreeGlobal initiative for chronic obstructive lung disease criteriaen_US
dc.subject.emtreeHealth surveyen_US
dc.subject.emtreeHospital admissionen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHypertensionen_US
dc.subject.emtreeInformed consenten_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMulticenter studyen_US
dc.subject.emtreeOccupationen_US
dc.subject.emtreePractice guidelineen_US
dc.subject.emtreeSmokingen_US
dc.subject.emtreeSocioeconomicsen_US
dc.subject.emtreeUniversity hospitalen_US
dc.subject.emtreeVaccinationen_US
dc.subject.emtreeChronic obstructive lung diseaseen_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeComplicationen_US
dc.subject.emtreeInfluenzaen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreePneumoniaen_US
dc.subject.emtreeQuestionnaireen_US
dc.subject.emtreeUtilizationen_US
dc.subject.emtreeVaccinationen_US
dc.subject.emtreeFemaleen_US
dc.subject.meshAgeden_US
dc.subject.meshCross-sectional studiesen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshInfluenza vaccinesen_US
dc.subject.meshInfluenza, humanen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshPneumococcal vaccinesen_US
dc.subject.meshPneumoniaen_US
dc.subject.meshPulmonary disease, chronic obstructiveen_US
dc.subject.meshSurveys and questionnairesen_US
dc.subject.meshVaccinationen_US
dc.subject.scopusInfluenza Vaccination; Pneumococcal Vaccines; Pharmacistsen_US
dc.subject.wosMedicine, general & internalen_US
dc.titleInfluenza and pneumonia vaccination rates and factors affecting vaccination among patients with chronic obstructive pulmonary diseaseen_US
dc.typeArticle
dc.wos.quartileQ3en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Görek_vd_2017.pdf
Size:
280.83 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: